The documentary special "Living Proof," produced by Sheryl Lee Ralph, will premiere on Hulu on Dec. 1 in honor of World AIDS ...
LGBTQ Nation on MSN
U.S. ships groundbreaking HIV drug to Africa, but slashed funding threatens progress
The U.S. just shipped two million doses of lenacapavir, a groundbreaking twice-a-year HIV-prevention injectable medication, ...
Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...
The Name on the Wall” unspools the short life of a French resistance foot soldier, whose ordinary bravery contrasted with the ...
Patient advocacy groups urged the South African government to issue a compulsory license for a groundbreaking HIV prevention ...
Opportunistic infections target people with weakened immune systems, including those with HIV. These conditions can lead to ...
It will unfold alongside the G20 Leaders Summit, creating a two-tier stage where economic and health decisions mingle, ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
As of 2024, over 40 million people in the world are diagnosed with human immunodeficiency virus (HIV)-a chronic, life-threatening infection that remains one of the leading global causes of death.
The United States, whose deep cuts to foreign aid this year under President Trump have severely impacted Africa’s health ...
The transition to outsourced offshore upstream manufacturing is expected to deliver substantial improvements in gross margin, EBITDA and cashflow generation. The move is part of a broader strategic ...
Trump administration touts moves to provide HIV prevention drug, but refuses to include South Africa
The US has started to provide doses of a Gilead HIV prevention drug to low-income countries, but the program will not include ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback